OpenAI acquired biotech startup Orchestra Bio to expand its life sciences AI tools

First reported by Quartz at · Updated · 2 sources

OpenAI will fold Orchestra's team and technology into Rosalind, its AI models and tools for life sciences researchers

Covered by 2 publishers within 15 hours of the first report.

Summary from Quartz.

Reporting2

Quartz OpenAI acquired biotech startup Orchestra Bio to expand its life sciences AI tools · Cris Tolomia
DigiTimes OpenAI acquires Orchestra Bio to advance AI drug development · DIGITIMES

Related

OpenAI reportedly in talks with startup to bring Sora back to life
Kevin Weil raises $215 million for AI drug development startup Warp Sciences
OpenAI Wants to ‘Patch the Planet’ (With Its Own AI)
OpenAI expands ChatGPT advertising availability to 89 countries

Topics OpenAI